1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Lequin, O.
Thuring, H.
Robin, M.
Lallemand, J.-Y.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
IX
Eur.J.Biochem.
EJBCAI
0262
0014-2956
250
712
726
10.1111/j.1432-1033.1997.00712.x
9461294
Three-dimensional solution structure of human angiogenin determined by 1H,15N-NMR spectroscopy--characterization of histidine protonation states and pKa values.
1997
10.2210/pdb1awz/pdb
pdb_00001awz
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
PANCREATIC RIBONUCLEASE SUPERFAMILY
14169.036
ANGIOGENIN
3.1.27.-
1
man
polymer
no
no
QDNSRYTHFLTQHYDAKPQGRDDRYCESIMRRRGLTSPCKDINTFIHGNKRSIKAICENKNGNPHRENLRISKSSFQVTT
CKLHGGSPWPPCQYRATAGFRNVVVACENGLPVHLDQSIFRRP
QDNSRYTHFLTQHYDAKPQGRDDRYCESIMRRRGLTSPCKDINTFIHGNKRSIKAICENKNGNPHRENLRISKSSFQVTT
CKLHGGSPWPPCQYRATAGFRNVVVACENGLPVHLDQSIFRRP
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
human
Homo
PLASMA
Escherichia
Escherichia coli
sample
9606
Homo sapiens
37762
Escherichia coli B
B
PLASMID
PXL694
database_2
pdbx_database_status
pdbx_struct_assembly
pdbx_struct_oper_list
repository
Initial release
Version format compliance
Version format compliance
Database references
Derived calculations
Other
1
0
1998-02-25
1
1
2008-03-24
1
2
2011-07-13
1
3
2022-02-16
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_database_status.process_site
Y
BNL
1997-10-07
REL
LEAST RESTRAINT VIOLATION
30
30
3D NOESY-HSQC
TOCSY-HMQC
HNHA
2D NOESY
150 mM
5.0
1
atm
313
K
CHARMM22 PARAMETER FILE RMS DEVIATION FROM EXPERIMENTAL DATA: NOE (A) : 0.0179 DIHEDRAL ANGLES (DEGREES) : 0.99
DISTANCE GEOMETRY, SIMULATED ANNEALING
BRUNGER
refinement
X-PLOR
3.1
structure solution
DIANA
structure solution
X-PLOR
600
Bruker
AMX600
GLN
1
n
1
GLN
1
A
ASP
2
n
2
ASP
2
A
ASN
3
n
3
ASN
3
A
SER
4
n
4
SER
4
A
ARG
5
n
5
ARG
5
A
TYR
6
n
6
TYR
6
A
THR
7
n
7
THR
7
A
HIS
8
n
8
HIS
8
A
PHE
9
n
9
PHE
9
A
LEU
10
n
10
LEU
10
A
THR
11
n
11
THR
11
A
GLN
12
n
12
GLN
12
A
HIS
13
n
13
HIS
13
A
TYR
14
n
14
TYR
14
A
ASP
15
n
15
ASP
15
A
ALA
16
n
16
ALA
16
A
LYS
17
n
17
LYS
17
A
PRO
18
n
18
PRO
18
A
GLN
19
n
19
GLN
19
A
GLY
20
n
20
GLY
20
A
ARG
21
n
21
ARG
21
A
ASP
22
n
22
ASP
22
A
ASP
23
n
23
ASP
23
A
ARG
24
n
24
ARG
24
A
TYR
25
n
25
TYR
25
A
CYS
26
n
26
CYS
26
A
GLU
27
n
27
GLU
27
A
SER
28
n
28
SER
28
A
ILE
29
n
29
ILE
29
A
MET
30
n
30
MET
30
A
ARG
31
n
31
ARG
31
A
ARG
32
n
32
ARG
32
A
ARG
33
n
33
ARG
33
A
GLY
34
n
34
GLY
34
A
LEU
35
n
35
LEU
35
A
THR
36
n
36
THR
36
A
SER
37
n
37
SER
37
A
PRO
38
n
38
PRO
38
A
CYS
39
n
39
CYS
39
A
LYS
40
n
40
LYS
40
A
ASP
41
n
41
ASP
41
A
ILE
42
n
42
ILE
42
A
ASN
43
n
43
ASN
43
A
THR
44
n
44
THR
44
A
PHE
45
n
45
PHE
45
A
ILE
46
n
46
ILE
46
A
HIS
47
n
47
HIS
47
A
GLY
48
n
48
GLY
48
A
ASN
49
n
49
ASN
49
A
LYS
50
n
50
LYS
50
A
ARG
51
n
51
ARG
51
A
SER
52
n
52
SER
52
A
ILE
53
n
53
ILE
53
A
LYS
54
n
54
LYS
54
A
ALA
55
n
55
ALA
55
A
ILE
56
n
56
ILE
56
A
CYS
57
n
57
CYS
57
A
GLU
58
n
58
GLU
58
A
ASN
59
n
59
ASN
59
A
LYS
60
n
60
LYS
60
A
ASN
61
n
61
ASN
61
A
GLY
62
n
62
GLY
62
A
ASN
63
n
63
ASN
63
A
PRO
64
n
64
PRO
64
A
HIS
65
n
65
HIS
65
A
ARG
66
n
66
ARG
66
A
GLU
67
n
67
GLU
67
A
ASN
68
n
68
ASN
68
A
LEU
69
n
69
LEU
69
A
ARG
70
n
70
ARG
70
A
ILE
71
n
71
ILE
71
A
SER
72
n
72
SER
72
A
LYS
73
n
73
LYS
73
A
SER
74
n
74
SER
74
A
SER
75
n
75
SER
75
A
PHE
76
n
76
PHE
76
A
GLN
77
n
77
GLN
77
A
VAL
78
n
78
VAL
78
A
THR
79
n
79
THR
79
A
THR
80
n
80
THR
80
A
CYS
81
n
81
CYS
81
A
LYS
82
n
82
LYS
82
A
LEU
83
n
83
LEU
83
A
HIS
84
n
84
HIS
84
A
GLY
85
n
85
GLY
85
A
GLY
86
n
86
GLY
86
A
SER
87
n
87
SER
87
A
PRO
88
n
88
PRO
88
A
TRP
89
n
89
TRP
89
A
PRO
90
n
90
PRO
90
A
PRO
91
n
91
PRO
91
A
CYS
92
n
92
CYS
92
A
GLN
93
n
93
GLN
93
A
TYR
94
n
94
TYR
94
A
ARG
95
n
95
ARG
95
A
ALA
96
n
96
ALA
96
A
THR
97
n
97
THR
97
A
ALA
98
n
98
ALA
98
A
GLY
99
n
99
GLY
99
A
PHE
100
n
100
PHE
100
A
ARG
101
n
101
ARG
101
A
ASN
102
n
102
ASN
102
A
VAL
103
n
103
VAL
103
A
VAL
104
n
104
VAL
104
A
VAL
105
n
105
VAL
105
A
ALA
106
n
106
ALA
106
A
CYS
107
n
107
CYS
107
A
GLU
108
n
108
GLU
108
A
ASN
109
n
109
ASN
109
A
GLY
110
n
110
GLY
110
A
LEU
111
n
111
LEU
111
A
PRO
112
n
112
PRO
112
A
VAL
113
n
113
VAL
113
A
HIS
114
n
114
HIS
114
A
LEU
115
n
115
LEU
115
A
ASP
116
n
116
ASP
116
A
GLN
117
n
117
GLN
117
A
SER
118
n
118
SER
118
A
ILE
119
n
119
ILE
119
A
PHE
120
n
120
PHE
120
A
ARG
121
n
121
ARG
121
A
ARG
122
n
122
ARG
122
A
PRO
123
n
123
PRO
123
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
A
O
ASN
43
A
O
ASN
43
A
N
CYS
81
A
N
CYS
81
A
O
PHE
76
A
O
PHE
76
A
N
ARG
101
A
N
ARG
101
A
O
ASN
63
A
O
ASN
63
A
N
ILE
71
A
N
ILE
71
A
O
ARG
70
A
O
ARG
70
A
N
VAL
105
A
N
VAL
105
A
O
ALA
106
A
O
ALA
106
A
N
HIS
114
A
N
HIS
114
6
A
A
H
H
ASN
LYS
59
60
1.17
20
A
A
H
H
LYS
SER
73
74
1.34
1
A
TYR
6
0.087
SIDE CHAIN
6
A
TYR
6
0.076
SIDE CHAIN
7
A
TYR
6
0.088
SIDE CHAIN
8
A
TYR
6
0.071
SIDE CHAIN
9
A
TYR
6
0.069
SIDE CHAIN
10
A
TYR
6
0.067
SIDE CHAIN
12
A
TYR
6
0.066
SIDE CHAIN
13
A
TYR
6
0.079
SIDE CHAIN
14
A
TYR
6
0.114
SIDE CHAIN
15
A
TYR
6
0.102
SIDE CHAIN
16
A
TYR
6
0.100
SIDE CHAIN
18
A
TYR
6
0.090
SIDE CHAIN
18
A
TYR
94
0.074
SIDE CHAIN
21
A
TYR
6
0.064
SIDE CHAIN
23
A
TYR
6
0.078
SIDE CHAIN
25
A
TYR
6
0.070
SIDE CHAIN
26
A
TYR
6
0.095
SIDE CHAIN
27
A
TYR
6
0.075
SIDE CHAIN
28
A
TYR
6
0.067
SIDE CHAIN
30
A
TYR
6
0.081
SIDE CHAIN
1
-5.00
0.60
121.00
116.00
A
A
A
CB
CG
CD2
TYR
TYR
TYR
6
6
6
N
1
-4.40
0.60
121.00
116.60
A
A
A
CB
CG
CD2
TYR
TYR
TYR
14
14
14
N
2
-11.50
1.90
110.20
98.70
A
A
A
CB
CA
C
LEU
LEU
LEU
10
10
10
N
3
-3.64
0.60
121.00
117.36
A
A
A
CB
CG
CD1
TYR
TYR
TYR
6
6
6
N
3
-12.59
1.90
110.20
97.61
A
A
A
CB
CA
C
LEU
LEU
LEU
10
10
10
N
3
4.56
0.70
120.80
125.36
A
A
A
CB
CG
CD1
PHE
PHE
PHE
120
120
120
N
4
-3.81
0.60
121.00
117.19
A
A
A
CB
CG
CD2
TYR
TYR
TYR
6
6
6
N
4
10.70
1.70
111.00
121.70
A
A
A
CB
CG
CD1
LEU
LEU
LEU
115
115
115
N
5
-4.55
0.60
121.00
116.45
A
A
A
CB
CG
CD1
TYR
TYR
TYR
6
6
6
N
5
-6.75
0.60
121.00
114.25
A
A
A
CB
CG
CD2
TYR
TYR
TYR
14
14
14
N
5
4.68
0.60
121.00
125.68
A
A
A
CB
CG
CD1
TYR
TYR
TYR
14
14
14
N
6
-5.73
0.60
121.00
115.27
A
A
A
CB
CG
CD2
TYR
TYR
TYR
6
6
6
N
6
-3.84
0.60
121.00
117.16
A
A
A
CB
CG
CD2
TYR
TYR
TYR
14
14
14
N
6
-9.91
1.60
100.20
90.29
A
A
A
CG
SD
CE
MET
MET
MET
30
30
30
N
7
-4.90
0.60
121.00
116.10
A
A
A
CB
CG
CD2
TYR
TYR
TYR
6
6
6
N
8
-5.51
0.60
121.00
115.49
A
A
A
CB
CG
CD2
TYR
TYR
TYR
14
14
14
N
8
4.43
0.60
121.00
125.43
A
A
A
CB
CG
CD1
TYR
TYR
TYR
14
14
14
N
9
-3.90
0.60
121.00
117.10
A
A
A
CB
CG
CD2
TYR
TYR
TYR
6
6
6
N
9
-4.21
0.60
121.00
116.79
A
A
A
CB
CG
CD2
TYR
TYR
TYR
14
14
14
N
10
-4.57
0.60
121.00
116.43
A
A
A
CB
CG
CD2
TYR
TYR
TYR
14
14
14
N
11
-4.44
0.60
121.00
116.56
A
A
A
CB
CG
CD1
TYR
TYR
TYR
6
6
6
N
11
11.76
1.90
110.20
121.96
A
A
A
CB
CA
C
LEU
LEU
LEU
10
10
10
N
12
-4.33
0.60
121.00
116.67
A
A
A
CB
CG
CD2
TYR
TYR
TYR
14
14
14
N
12
11.04
1.70
111.00
122.04
A
A
A
CB
CG
CD1
LEU
LEU
LEU
115
115
115
N
12
-4.23
0.70
120.80
116.57
A
A
A
CB
CG
CD1
PHE
PHE
PHE
120
120
120
N
13
11.80
1.90
110.20
122.00
A
A
A
CB
CA
C
LEU
LEU
LEU
10
10
10
N
13
-4.18
0.60
121.00
116.82
A
A
A
CB
CG
CD2
TYR
TYR
TYR
14
14
14
N
14
-5.07
0.60
121.00
115.93
A
A
A
CB
CG
CD2
TYR
TYR
TYR
6
6
6
N
15
11.92
1.90
110.20
122.12
A
A
A
CB
CA
C
LEU
LEU
LEU
10
10
10
N
16
-4.67
0.60
121.00
116.33
A
A
A
CB
CG
CD2
TYR
TYR
TYR
6
6
6
N
16
-4.55
0.60
121.00
116.45
A
A
A
CB
CG
CD2
TYR
TYR
TYR
14
14
14
N
17
11.59
1.90
110.20
121.79
A
A
A
CB
CA
C
LEU
LEU
LEU
10
10
10
N
17
-3.76
0.60
121.00
117.24
A
A
A
CB
CG
CD1
TYR
TYR
TYR
14
14
14
N
18
-6.87
0.60
121.00
114.13
A
A
A
CB
CG
CD2
TYR
TYR
TYR
6
6
6
N
18
5.15
0.60
121.00
126.15
A
A
A
CB
CG
CD1
TYR
TYR
TYR
6
6
6
N
18
-3.92
0.60
121.00
117.08
A
A
A
CB
CG
CD2
TYR
TYR
TYR
14
14
14
N
19
-4.12
0.60
121.00
116.88
A
A
A
CB
CG
CD1
TYR
TYR
TYR
6
6
6
N
19
4.53
0.70
120.80
125.33
A
A
A
CB
CG
CD1
PHE
PHE
PHE
120
120
120
N
20
-5.34
0.60
121.00
115.66
A
A
A
CB
CG
CD1
TYR
TYR
TYR
6
6
6
N
20
-4.75
0.60
121.00
116.25
A
A
A
CB
CG
CD2
TYR
TYR
TYR
14
14
14
N
20
11.11
1.70
111.00
122.11
A
A
A
CB
CG
CD1
LEU
LEU
LEU
115
115
115
N
22
-5.26
0.60
121.00
115.74
A
A
A
CB
CG
CD2
TYR
TYR
TYR
6
6
6
N
22
-5.10
0.70
120.80
115.70
A
A
A
CB
CG
CD2
PHE
PHE
PHE
120
120
120
N
22
5.83
0.70
120.80
126.63
A
A
A
CB
CG
CD1
PHE
PHE
PHE
120
120
120
N
23
-7.21
0.60
121.00
113.79
A
A
A
CB
CG
CD2
TYR
TYR
TYR
6
6
6
N
23
5.95
0.60
121.00
126.95
A
A
A
CB
CG
CD1
TYR
TYR
TYR
6
6
6
N
23
-4.23
0.70
120.80
116.57
A
A
A
CB
CG
CD2
PHE
PHE
PHE
120
120
120
N
23
4.67
0.70
120.80
125.47
A
A
A
CB
CG
CD1
PHE
PHE
PHE
120
120
120
N
24
5.13
0.60
121.00
126.13
A
A
A
CB
CG
CD2
TYR
TYR
TYR
6
6
6
N
24
-6.81
0.60
121.00
114.19
A
A
A
CB
CG
CD1
TYR
TYR
TYR
6
6
6
N
25
-3.84
0.60
121.00
117.16
A
A
A
CB
CG
CD2
TYR
TYR
TYR
14
14
14
N
26
-4.95
0.60
121.00
116.05
A
A
A
CB
CG
CD2
TYR
TYR
TYR
14
14
14
N
27
-4.69
0.60
121.00
116.31
A
A
A
CB
CG
CD2
TYR
TYR
TYR
6
6
6
N
28
-4.68
0.60
121.00
116.32
A
A
A
CB
CG
CD2
TYR
TYR
TYR
6
6
6
N
28
11.14
1.70
111.00
122.14
A
A
A
CB
CG
CD1
LEU
LEU
LEU
115
115
115
N
29
5.59
0.60
121.00
126.59
A
A
A
CB
CG
CD2
TYR
TYR
TYR
6
6
6
N
29
-7.37
0.60
121.00
113.63
A
A
A
CB
CG
CD1
TYR
TYR
TYR
6
6
6
N
29
10.20
1.70
111.00
121.20
A
A
A
CB
CG
CD1
LEU
LEU
LEU
115
115
115
N
30
-5.82
0.60
121.00
115.18
A
A
A
CB
CG
CD2
TYR
TYR
TYR
6
6
6
N
30
16.95
2.20
113.40
130.35
A
A
A
CA
CB
CG
GLN
GLN
GLN
77
77
77
N
1
A
ASP
2
59.34
71.83
1
A
ASN
3
93.15
-28.84
1
A
ARG
21
-106.84
73.46
1
A
ARG
66
46.31
-109.59
1
A
GLU
67
-107.33
77.47
1
A
GLN
117
-100.86
41.84
1
A
PHE
120
-105.06
43.40
2
A
ASN
3
109.36
-26.04
2
A
GLN
19
-74.64
-74.99
2
A
ARG
21
-118.16
72.56
2
A
LYS
60
-159.77
-49.08
2
A
ASN
61
-144.34
47.24
2
A
ARG
66
65.66
-108.72
2
A
SER
74
-109.54
74.02
3
A
ASP
2
-102.74
68.01
3
A
HIS
13
-127.29
-62.94
3
A
ARG
21
-109.53
68.28
3
A
ARG
66
60.50
-109.81
3
A
GLN
117
-114.20
59.53
4
A
ASN
3
111.67
-35.32
4
A
GLN
19
-70.10
-76.65
4
A
ARG
21
-112.63
74.47
4
A
ARG
66
65.51
-102.49
4
A
GLN
117
-106.59
51.04
5
A
ASN
3
81.71
5.78
5
A
ARG
66
66.29
-103.21
5
A
GLU
67
-163.36
113.75
5
A
HIS
84
-142.10
46.85
5
A
PHE
100
-162.28
101.61
5
A
GLN
117
-96.18
37.44
6
A
ASP
2
-116.50
59.99
6
A
GLN
19
-73.21
-73.05
6
A
ARG
21
-115.16
72.81
6
A
ASN
59
-159.88
-3.46
6
A
ARG
66
66.39
-103.59
6
A
ASN
68
90.93
-12.70
6
A
ASN
109
31.95
68.55
7
A
ASP
2
-108.31
60.69
7
A
GLN
19
-70.08
-77.97
7
A
ARG
21
-110.15
74.67
7
A
LYS
60
-141.06
-46.51
7
A
ARG
66
70.81
-103.91
7
A
SER
87
-163.51
110.74
7
A
GLN
117
-106.06
41.06
8
A
HIS
13
-123.64
-55.59
8
A
ARG
21
-109.38
75.53
8
A
ARG
66
69.85
-97.13
8
A
GLN
117
-105.41
42.11
9
A
ASP
2
-111.34
62.96
9
A
ASN
61
73.64
36.14
9
A
ARG
66
49.47
-107.33
9
A
GLU
67
-103.74
77.53
9
A
GLN
117
-101.30
41.76
10
A
ARG
21
-112.03
74.40
10
A
GLU
58
-106.58
53.12
10
A
ASN
59
79.44
-35.97
10
A
ASN
61
26.96
55.70
10
A
PHE
120
-105.29
47.88
10
A
ARG
121
-128.37
-53.37
11
A
ASP
2
-115.01
53.17
11
A
ASP
41
-63.50
-74.38
11
A
CYS
57
-99.64
42.93
11
A
LYS
60
-133.06
-35.39
11
A
ARG
66
72.12
-101.53
11
A
PHE
100
-163.53
106.25
12
A
ASP
2
71.33
64.72
12
A
ASN
3
77.15
-3.81
12
A
GLN
19
-74.86
-71.54
12
A
ASN
59
56.25
-87.51
12
A
ARG
66
66.68
-111.44
13
A
GLN
19
-73.30
-70.19
13
A
ARG
21
-116.10
72.57
13
A
ARG
66
61.84
-96.67
13
A
GLN
117
-103.84
44.28
14
A
ASN
3
80.83
2.61
14
A
CYS
57
-98.80
34.88
14
A
ASN
59
26.23
46.35
14
A
ARG
66
81.56
-100.31
14
A
GLU
67
-105.34
78.03
14
A
GLN
117
-99.96
43.16
14
A
PHE
120
-109.94
48.47
15
A
ASP
2
-114.61
53.68
15
A
ARG
21
-113.30
72.91
15
A
ARG
66
65.76
-99.49
15
A
GLU
67
-101.42
72.39
15
A
PHE
100
-162.38
108.95
15
A
PHE
120
-106.97
54.26
15
A
ARG
121
62.57
77.69
16
A
ASP
2
-110.77
62.60
16
A
GLN
19
-75.16
-71.39
16
A
ARG
21
-114.68
70.61
16
A
ARG
66
66.46
-107.20
16
A
SER
74
-106.37
77.26
16
A
LEU
115
-170.26
132.88
16
A
ARG
121
-91.42
-66.91
17
A
ARG
66
63.46
-105.20
17
A
PHE
100
-160.62
107.97
17
A
GLN
117
-102.08
40.26
18
A
ASP
2
-114.02
61.86
18
A
GLN
19
-73.25
-79.77
18
A
ARG
66
67.94
-100.26
18
A
GLU
67
-162.57
108.80
18
A
ASN
68
86.71
-6.66
18
A
SER
74
-103.03
79.78
18
A
GLN
117
-105.16
42.09
18
A
PHE
120
-105.61
41.45
19
A
GLN
19
-75.78
-73.87
19
A
LEU
35
-143.16
23.35
19
A
GLU
58
-102.07
57.31
19
A
ASN
59
34.81
65.48
19
A
LYS
60
-131.94
-58.76
19
A
ARG
66
69.49
-101.28
19
A
GLU
67
-105.96
77.21
19
A
SER
74
-105.39
79.55
19
A
ARG
121
-84.30
-73.61
20
A
ASN
3
82.65
6.25
20
A
GLN
19
-70.87
-77.65
20
A
ARG
21
-118.29
72.29
20
A
CYS
57
-103.43
44.34
20
A
ARG
66
64.59
-102.65
20
A
LYS
73
-148.68
-0.08
20
A
GLN
117
-110.56
51.24
21
A
ASP
2
66.64
83.10
21
A
ASN
3
101.14
-32.83
21
A
GLN
12
-67.82
-70.33
21
A
ARG
21
-114.60
66.43
21
A
LYS
60
-130.73
-47.52
21
A
ASN
61
-143.99
58.55
21
A
ARG
66
65.20
-107.39
22
A
ARG
66
62.21
156.56
22
A
SER
74
-106.28
78.86
22
A
PHE
120
-103.00
52.98
23
A
LYS
60
-160.14
-57.74
23
A
ARG
66
65.54
-102.26
23
A
PHE
120
-105.97
56.80
24
A
ASP
2
-118.36
51.53
24
A
ARG
66
62.11
-103.26
24
A
GLN
117
-96.80
36.89
25
A
ASP
2
61.36
65.79
25
A
ASN
3
81.36
-6.71
25
A
ARG
21
-115.87
73.64
25
A
GLU
58
-95.74
51.26
25
A
ASN
61
14.52
56.54
25
A
ARG
66
63.42
-108.61
25
A
ASN
109
75.94
-12.00
25
A
GLN
117
-100.07
40.19
25
A
PHE
120
-106.12
40.10
26
A
ASP
2
75.15
78.32
26
A
ASN
3
79.21
-2.43
26
A
ASN
61
-113.71
51.20
26
A
GLU
67
-104.24
75.36
26
A
PHE
120
-97.48
37.79
26
A
ARG
121
61.26
67.39
27
A
ASP
2
-117.26
55.75
27
A
ASN
61
84.95
-8.44
27
A
ARG
66
53.82
152.27
27
A
ASN
68
83.89
1.45
27
A
GLN
117
-115.65
56.71
28
A
GLN
19
-72.59
-73.36
28
A
ARG
21
-111.80
75.97
28
A
ASN
59
73.33
-136.90
28
A
ARG
66
64.66
-107.01
28
A
GLN
117
-108.84
52.05
29
A
ASN
3
84.88
11.20
29
A
GLN
19
-72.87
-70.53
29
A
ARG
21
-116.66
73.62
29
A
ARG
66
62.08
-106.45
29
A
VAL
113
-147.40
-27.14
29
A
GLN
117
-103.94
45.67
30
A
ASP
2
-108.55
58.77
30
A
ARG
21
-118.92
55.03
30
A
ASN
59
32.10
47.58
30
A
ASN
61
-118.55
64.71
30
A
ARG
66
61.12
157.62
30
A
GLN
117
-101.88
40.77
30
A
PHE
120
-103.43
43.47
30
A
ARG
121
-153.34
-50.03
model building
X-PLOR
3.1
refinement
X-PLOR
3.1
phasing
X-PLOR
3.1
3D SOLUTION STRUCTURE OF HUMAN ANGIOGENIN DETERMINED BY 1H, 15N NMR SPECTROSCOPY, 30 STRUCTURES
1
Y
N
A
SER
4
A
SER
4
HELX_P
A
GLN
12
A
GLN
12
1
1
9
A
ASP
23
A
ASP
23
HELX_P
A
ARG
33
A
ARG
33
1
2
11
A
LYS
50
A
LYS
50
HELX_P
A
ILE
56
A
ILE
56
1
3
7
disulf
2.001
A
CYS
26
A
SG
CYS
26
1_555
A
CYS
81
A
SG
CYS
81
1_555
disulf
2.018
A
CYS
39
A
SG
CYS
39
1_555
A
CYS
92
A
SG
CYS
92
1_555
disulf
2.021
A
CYS
57
A
SG
CYS
57
1_555
A
CYS
107
A
SG
CYS
107
1_555
HYDROLASE
HYDROLASE, ENDORIBONUCLEASE, ANGIOGENESIS
A
SER
37
A
SER
37
1
A
PRO
38
A
PRO
38
-18.48
A
PRO
90
A
PRO
90
1
A
PRO
91
A
PRO
91
15.85
A
SER
37
A
SER
37
2
A
PRO
38
A
PRO
38
-20.25
A
PRO
90
A
PRO
90
2
A
PRO
91
A
PRO
91
-1.76
A
SER
37
A
SER
37
3
A
PRO
38
A
PRO
38
-21.87
A
PRO
90
A
PRO
90
3
A
PRO
91
A
PRO
91
7.37
A
SER
37
A
SER
37
4
A
PRO
38
A
PRO
38
-22.02
A
PRO
90
A
PRO
90
4
A
PRO
91
A
PRO
91
9.41
A
SER
37
A
SER
37
5
A
PRO
38
A
PRO
38
-20.63
A
PRO
90
A
PRO
90
5
A
PRO
91
A
PRO
91
1.88
A
SER
37
A
SER
37
6
A
PRO
38
A
PRO
38
-24.60
A
PRO
90
A
PRO
90
6
A
PRO
91
A
PRO
91
10.81
A
SER
37
A
SER
37
7
A
PRO
38
A
PRO
38
-22.45
A
PRO
90
A
PRO
90
7
A
PRO
91
A
PRO
91
-4.44
A
SER
37
A
SER
37
8
A
PRO
38
A
PRO
38
-22.19
A
PRO
90
A
PRO
90
8
A
PRO
91
A
PRO
91
12.33
A
SER
37
A
SER
37
9
A
PRO
38
A
PRO
38
-27.48
A
PRO
90
A
PRO
90
9
A
PRO
91
A
PRO
91
5.47
A
SER
37
A
SER
37
10
A
PRO
38
A
PRO
38
-19.22
A
PRO
90
A
PRO
90
10
A
PRO
91
A
PRO
91
19.08
A
SER
37
A
SER
37
11
A
PRO
38
A
PRO
38
-24.78
A
PRO
90
A
PRO
90
11
A
PRO
91
A
PRO
91
10.92
A
SER
37
A
SER
37
12
A
PRO
38
A
PRO
38
-23.72
A
PRO
90
A
PRO
90
12
A
PRO
91
A
PRO
91
9.80
A
SER
37
A
SER
37
13
A
PRO
38
A
PRO
38
-19.75
A
PRO
90
A
PRO
90
13
A
PRO
91
A
PRO
91
3.11
A
SER
37
A
SER
37
14
A
PRO
38
A
PRO
38
-16.15
A
PRO
90
A
PRO
90
14
A
PRO
91
A
PRO
91
7.88
A
SER
37
A
SER
37
15
A
PRO
38
A
PRO
38
-22.37
A
PRO
90
A
PRO
90
15
A
PRO
91
A
PRO
91
13.11
A
SER
37
A
SER
37
16
A
PRO
38
A
PRO
38
-20.92
A
PRO
90
A
PRO
90
16
A
PRO
91
A
PRO
91
4.11
A
SER
37
A
SER
37
17
A
PRO
38
A
PRO
38
-22.42
A
PRO
90
A
PRO
90
17
A
PRO
91
A
PRO
91
7.62
A
SER
37
A
SER
37
18
A
PRO
38
A
PRO
38
-25.01
A
PRO
90
A
PRO
90
18
A
PRO
91
A
PRO
91
-1.10
A
SER
37
A
SER
37
19
A
PRO
38
A
PRO
38
-18.68
A
PRO
90
A
PRO
90
19
A
PRO
91
A
PRO
91
7.82
A
SER
37
A
SER
37
20
A
PRO
38
A
PRO
38
-22.13
A
PRO
90
A
PRO
90
20
A
PRO
91
A
PRO
91
5.84
A
SER
37
A
SER
37
21
A
PRO
38
A
PRO
38
-23.27
A
PRO
90
A
PRO
90
21
A
PRO
91
A
PRO
91
10.26
A
SER
37
A
SER
37
22
A
PRO
38
A
PRO
38
-19.80
A
PRO
90
A
PRO
90
22
A
PRO
91
A
PRO
91
4.86
A
SER
37
A
SER
37
23
A
PRO
38
A
PRO
38
-23.36
A
PRO
90
A
PRO
90
23
A
PRO
91
A
PRO
91
-4.78
A
SER
37
A
SER
37
24
A
PRO
38
A
PRO
38
-23.41
A
PRO
90
A
PRO
90
24
A
PRO
91
A
PRO
91
13.08
A
SER
37
A
SER
37
25
A
PRO
38
A
PRO
38
-21.04
A
PRO
90
A
PRO
90
25
A
PRO
91
A
PRO
91
12.97
A
SER
37
A
SER
37
26
A
PRO
38
A
PRO
38
-21.10
A
PRO
90
A
PRO
90
26
A
PRO
91
A
PRO
91
8.59
A
SER
37
A
SER
37
27
A
PRO
38
A
PRO
38
-21.59
A
PRO
90
A
PRO
90
27
A
PRO
91
A
PRO
91
-1.78
A
SER
37
A
SER
37
28
A
PRO
38
A
PRO
38
-24.62
A
PRO
90
A
PRO
90
28
A
PRO
91
A
PRO
91
10.71
A
SER
37
A
SER
37
29
A
PRO
38
A
PRO
38
-22.25
A
PRO
90
A
PRO
90
29
A
PRO
91
A
PRO
91
8.88
A
SER
37
A
SER
37
30
A
PRO
38
A
PRO
38
-22.03
A
PRO
90
A
PRO
90
30
A
PRO
91
A
PRO
91
-1.09
ANGI_HUMAN
UNP
1
1
P03950
MVMGLGVLLLVFVLGLGLTPPTLAQDNSRYTHFLTQHYDAKPQGRDDRYCESIMRRRGLTSPCKDINTFIHGNKRSIKAI
CENKNGNPHRENLRISKSSFQVTTCKLHGGSPWPPCQYRATAGFRNVVVACENGLPVHLDQSIFRRP
25
147
1AWZ
1
123
P03950
A
1
1
123
3
4
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
A
ILE
42
A
ILE
42
A
HIS
47
A
HIS
47
A
PHE
76
A
PHE
76
A
LEU
83
A
LEU
83
A
TYR
94
A
TYR
94
A
ARG
101
A
ARG
101
A
GLY
62
A
GLY
62
A
HIS
65
A
HIS
65
A
LEU
69
A
LEU
69
A
SER
72
A
SER
72
A
VAL
104
A
VAL
104
A
GLU
108
A
GLU
108
A
LEU
111
A
LEU
111
A
LEU
115
A
LEU
115
RIBONUCLEOLYTIC ACTIVE SITE.
Unknown
8
PUTATIVE CELL RECEPTOR BINDING SITE.
Unknown
6
NUCLEOLAR LOCALIZATION SIGNAL.
Unknown
3
A
GLN
12
A
GLN
12
8
1_555
A
HIS
13
A
HIS
13
8
1_555
A
LYS
40
A
LYS
40
8
1_555
A
THR
44
A
THR
44
8
1_555
A
HIS
114
A
HIS
114
8
1_555
A
LEU
115
A
LEU
115
8
1_555
A
ASP
116
A
ASP
116
8
1_555
A
GLN
117
A
GLN
117
8
1_555
A
LYS
60
A
LYS
60
6
1_555
A
ASN
61
A
ASN
61
6
1_555
A
ARG
66
A
ARG
66
6
1_555
A
GLU
67
A
GLU
67
6
1_555
A
ASN
68
A
ASN
68
6
1_555
A
ASN
109
A
ASN
109
6
1_555
A
ARG
31
A
ARG
31
3
1_555
A
ARG
32
A
ARG
32
3
1_555
A
ARG
33
A
ARG
33
3
1_555
1
P 1